- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/26 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 239/26
Total number of patents in this class: 1117
10-year publication summary
|
100
|
106
|
78
|
83
|
73
|
84
|
71
|
78
|
74
|
41
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17643 |
55 |
| Solus Advanced Materials Co., Ltd. | 207 |
30 |
| Bristol-myers Squibb Company | 4867 |
29 |
| Merck Patent GmbH | 5820 |
22 |
| Novaled GmbH | 446 |
20 |
| Idemitsu Kosan Co., Ltd. | 4222 |
19 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 264 |
17 |
| Amgen Inc. | 4097 |
16 |
| Semiconductor Energy Laboratory Co., Ltd. | 11471 |
15 |
| JNC Corporation | 1563 |
15 |
| JNC Petrochemical Corporation | 400 |
14 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3178 |
14 |
| Nodthera Limited | 39 |
12 |
| Novartis AG | 10726 |
11 |
| BASF SE | 20961 |
11 |
| Tosoh Corporation | 1310 |
11 |
| UCB Biopharma SRL | 580 |
11 |
| Abbvie Inc. | 1799 |
10 |
| Samsung Display Co., Ltd. | 35100 |
9 |
| Boehringer Ingelheim International GmbH | 4640 |
9 |
| Other owners | 767 |